Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ding Ren

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Journal of Biomolecular Screening|September 25, 2013
Development of novel, 384-well high-throughput assay panels for human drug transporters: drug interaction and safety assessment in support of discovery researchHuaping Tang, Ding Ren Shen, Yong-Hae Han, et al.
Journal of Biomolecular Screening|May 3, 2014
Integrating High-Content Analysis into a Multiplexed Screening Approach to Identify and Characterize GPCR AgonistsYingjie Zhu, John Watson, Mengjie Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Molecular design, synthesis, and structure-Activity relationships leading to the potent and selective p56(lck) inhibitor BMS-243117Jagabandhu Das, James Lin, Robert V Moquin, et al.
The New Phytologist|October 22, 2020
Strong photoperiod sensitivity is controlled by cooperation and competition among Hd1, Ghd7 and DTH8 in rice headingWubei Zong, Ding Ren, Minghui Huang, et al.
The New Phytologist|April 1, 2023
CorrigendumWubei Zong, Ding Ren, Minghui Huang, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56(Lck)John Wityak, Jagabandhu Das, Robert V Moquin, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: improvement of cell potencyPing Chen, Edwin J Iwanowicz, Derek Norris, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2020
Discovery of 2,6-difluorobenzyl ether series of phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonistsJames J-W Duan, Bin Jiang, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2008
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitorsJagabandhu Das, Robert V Moquin, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56(Lck) inhibitorsPing Chen, Derek Norris, Jagabandhu Das, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Journal of Biomolecular Screening|September 25, 2013
Development of novel, 384-well high-throughput assay panels for human drug transporters: drug interaction and safety assessment in support of discovery researchHuaping Tang, Ding Ren Shen, Yong-Hae Han, et al.
Journal of Biomolecular Screening|May 3, 2014
Integrating High-Content Analysis into a Multiplexed Screening Approach to Identify and Characterize GPCR AgonistsYingjie Zhu, John Watson, Mengjie Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Molecular design, synthesis, and structure-Activity relationships leading to the potent and selective p56(lck) inhibitor BMS-243117Jagabandhu Das, James Lin, Robert V Moquin, et al.
The New Phytologist|October 22, 2020
Strong photoperiod sensitivity is controlled by cooperation and competition among Hd1, Ghd7 and DTH8 in rice headingWubei Zong, Ding Ren, Minghui Huang, et al.
The New Phytologist|April 1, 2023
CorrigendumWubei Zong, Ding Ren, Minghui Huang, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56(Lck)John Wityak, Jagabandhu Das, Robert V Moquin, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: improvement of cell potencyPing Chen, Edwin J Iwanowicz, Derek Norris, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2020
Discovery of 2,6-difluorobenzyl ether series of phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonistsJames J-W Duan, Bin Jiang, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2008
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitorsJagabandhu Das, Robert V Moquin, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56(Lck) inhibitorsPing Chen, Derek Norris, Jagabandhu Das, et al.
Pageof 9